The abrogated role of premedication in the prevention of transfusion-associated adverse reactions in outpatients receiving leukocyte-reduced blood components.

Yuan-Bin YuTai-Chen LeeChun-Yee HoHui-Jung LinWei-Chi ChenChih-Chun Chang

Published in: Vox sanguinis (2022)

Decreased premedication was not associated with increased incidence of TAARs in outpatients; these findings provide important evidence to support the need to revise clinical practices in the era of leukocyte-reduced blood products.

Keyphrases

healthcare
primary care
peripheral blood
risk factors
cardiac surgery
sickle cell disease
adverse drug